Effective July 1, 2023, PlushCare, Inc. has updated our Privacy Policy. Your continued use of PlushCare online services will confirm that you have reviewed and agreed to our updated Privacy Policy.

Mounjaro (tirzepatide) for weight loss prescription online

Mounjaro (tirzepatide) is an injectable prescription to treat type 2 diabetes that has shown to be extremely effective in improving blood sugar levels in adults with type 2 diabetes. Additional benefits may include weight loss. Speak to one of our trusted, board-certified doctors about how Mounjaro could be right for you.*

Book an appointment

Whole-patient centered care, available anywhere

Board-certified physicians and lab tests

Insurance accepted, but not required


GLP-1 medication if prescribed*

*Prescriptions provided at doctor’s discretion. Learn more about our controlled substances policy.

Most major insurance plans accepted

Most patients with in-network insurance pay $30 or less. Paying without insurance? New patient visits are $129, and follow-ups are only $99 for members.

Don’t see your provider listed? Email [email protected]  or call  (888) 564-4454  to talk to a PlushCare specialist.

3 simple steps to discuss your Mounjaro prescription

Step 1

Book a visit with a doctor to discuss Mounjaro.

During your first visit, your PlushCare doctor will review your medical history and health goals.

Step 2

Talk to your physician regarding a Mounjaro prescription.

Visit with a doctor on your smartphone or computer. Often, lab work is required, and they’ll send an order to your preferred lab. Once your results are available, your doctor will review them with you and discuss treatment options.

Step 3

Pick up your Mounjaro prescription, if prescribed.

Prescriptions are provided based on eligibility and safety.  Our physicians will prescribe medications, help you set diet and exercise goals, and monitor your weight loss progress.  Learn more about the cost of Mounjaro and whether a prior authorization is needed in the FAQ section below.

PlushCare pricing details

How pricing works

To discuss Mounjaro, become a member for medically guided weight management. We also offer free certified health coaches to help you lose weight and build a healthy diet and exercise plan.*

Paying with insurance

Membership

$14.99/month

First month free

First visit

Copay

For all visits

30 days of free membership

  • Same-day appointments 7 days a week

  • Unlimited messages with your Care Team

  • Prescription discount card to save up to 80%

  • Exclusive discounts on lab tests

  • Free memberships for your family

  • Cancel anytime

Visit price with insurance

Often the same as an office visit. Most patients with in-network insurance pay $30 or less!

  • We accept these insurance plans and many more:

    • Humana
    • Aetna
    • United Healthcare

Paying without insurance

Membership

$14.99/month

First month free

First visit

$129

Repeats only $99

30 days of free membership

  • Same-day appointments 7 days a week

  • Unlimited messages with your Care Team

  • Prescription discount card to save up to 80%

  • Exclusive discounts on lab tests

  • Free memberships for your family

  • Cancel anytime

Visit price without insurance

Initial visits are $129 and follow-ups are only $99 for active members.

Book an appointment

*If we're unable to treat you, we'll provide a full refund. Please note that any medication or lab work costs are not included.

Mounjaro prescription FAQs

  • How can I get Mounjaro for weight loss?

    To get Mounjaro for weight loss, you will need to speak to a board-certified doctor to begin the evaluation process and complete any necessary lab tests. Although Mounjaro can promote weight loss, it is a medication to treat type 2 diabetes.

    Book an appointment with one of our board-certified doctors online to discuss if you can qualify for Mounjaro and begin the evaluation process.

  • How do you qualify for Mounjaro?

    Mounjaro is a new type 2 diabetes drug that can also help with weight loss. If you have diabetes and are struggling with weight loss, speak with one of our trusted, board-certified physicians online to discuss your health concerns and start the evaluation process for Mounjaro. This would include discussing your medical history and current medication and ordering baseline tests and studies to determine if you qualify for a Mounjaro prescription.

    Wegovy and Saxenda are type 2 diabetes medications that are extremely effective for weight loss. They have now been approved for weight loss only without type 2 diabetes. Speak to one of our trusted, board-certified doctors about how Wegovy and Saxenda could be right for you.

  • Can I get a Mounjaro prescription online?

    You may be able to get a Mounjaro prescription online after meeting with a doctor to discuss your medical history and completing any necessary evaluations.


    You can been the evaluation process for Mounjaro online with one of our board-certified doctors. If you have diabetes and are looking for weight management options, book an appointment with one our our top rated doctors online. After ordering any necessary lab tests and reviewing your results, if you qualify, your doctor can electronically send a prescription to your local pharmacy.

  • How does Mounjaro work for weight loss?

    Mounjaro works for weight loss by reducing hunger and slowing digestion.

  • Is Mounjaro approved for weight loss?

    Although Mounjaro can promote weight loss, it has only been FDA-approved to treat type 2 diabetes.

  • How does Mounjaro work?

    Tirzepatide is what is known as a “dual glucose-dependent insulinotropic polypeptide–GLP-1 receptor agonist.”  This long and complicated name means it can do two things:

    1. Stimulate GLP-1 receptors in the body to both help control blood sugar and reduce hunger, promoting weight loss.

    2. Promote release of glucose-dependent insulinotropic polypeptide which helps modulate levels of a hormone called glucagon and improve insulin sensitivity of adipose (fat) tissue.

  • Is Mounjaro the same as Ozempic?

    Mounjaro and Ozempic are in the same class of drugs, but work via different mechanisms. Mounjaro works on GIP and GLP-1 receptors, while Ozempic only works on GLP-1 receptors. Both are used to treat type 2 diabetes and can promote weight loss. To find out which one is right for you, speak to one of our board-certified doctors.

  • How much does Mounjaro cost?

    If you qualify for a Mounjaro prescription and the drug is included in your insurance plan’s formulary, your monthly cost may vary.  Most branded weight loss medications require prior authorization for insurance to cover the cost. Your PlushCare physician and care team will reach out to your insurer on your behalf, and this process can take several business days. If you are denied the prior authorization or do not have health insurance, you may still purchase the medication at the total cash price. It is important to note that a type 2 diabetes diagnosis is usually required for insurance approval of this medication.

    Learn more about prior authorizations for weight loss medications.

    The makers of tirzepatide/Mounjaro (Lilly) are currently offering a co-pay savings card of $25 per month for specific individuals who qualify, which can be found on their website. Unfortunately, Mounjaro is expensive without insurance, ranging around $1000/month, depending on the pharmacy.

  • Am I eligible for the Mounjaro Savings Card?

    A limited number of patients may be eligible for the Mounjaro Saving Card, which allows certain patients to pay as little as $25 for a one-month or three-month supply of Mounjaro. You will likely need a type 2 diabetes diagnosis for eligibility. To find out if you are eligible, complete the enrollment form on the Mounjaro website.

  • What does Mounjaro do to your body?

    Mounjaro helps control blood sugar and reduce hunger by releasing more insulin, less sugar, and slowing down digestion. This helps treat diabetes and can promote weight loss.

  • Can I get tirzepatide yet?

    Production and distribution of tirzepatide to pharmacies began in June 2022, but there is limited availability.

  • What have been the results of the Mounjaro clinical trials?

    A study published in 2021 called SURPASS-2 on over 1800 participants found that Mounjaro (tirzepatide) + metformin was superior to semaglutide +metformin on reduction in Hemoglobin A1C in individuals with Type 2 Diabetes.  When evaluating tirzepatide vs. semaglutide, as a secondary endpoint, 5.5% more weight loss was noted in the tirzepatide group compared to the semaglutide group.

    The most recent clinical trial awaiting publication, called SURMOUNT-1, reports that the average weight loss among over 2500 trial participants was 16% at 72 weeks.  Adults who were randomly assigned to receive tirzepatide had average weight losses of 16% with 5 mg of the drug, 21.4% with 10 mg, and 22.5% with 15 mg, compared with only 2.4% weight loss with participants who took a placebo. Of the tirzepatide group, 89% achieved a weight loss of at least 5% compared with 28% in the placebo group as well. The average BMI of trial participants starting off was 38, and was reduced to an average of 30, with many subjects getting into the normal range.

    The SURMOUNT-1 trial is still ongoing, and additional key outcome measures under study include progression to type 2 diabetes among patients with prediabetes.  It is anticipated that the trial will be continued for a total of an additional 104 weeks.

  • How does Mounjaro compare to similar weight loss medications, or weight loss surgery?

    Keep in mind that currently Mounjaro (tirzepatide) is not technically FDA-approved for weight loss, but to treat diabetes.  But based on the results of SURMOUNT-1, if Mounjaro was approved for weight loss, it would easily become the most effective drug available. Given that it has two different mechanisms of action, it appears to have a greater effect on weight and blood sugar than GLP-1 agonist drugs alone, such as semaglutide or liraglutide, which are both currently FDA approved for sugar and weight control under different trade names. So when comparing tirzepatide vs. semaglutide, liraglutide, or other diabetes medicines, it seems to be much more effective.

    Given that over half the patients on the 10 mg dose and 63% of those on the 15 mg dose lost more than 20% of their body weight, this number takes many past the weight loss achieved long term with surgical interventions such as the lap-band, and is within the typical ranges achieved long term with procedures such as the sleeve gastrectomy.

About Mounjaro (tirzepatide)

Mounjaro (tirzepatide) is a weekly injection that lowers blood glucose in adults with type 2 diabetes. It should be used in combination with diet and exercise. Mounjaro has also been shown in clinical trials to help with weight loss, but the FDA has not approved it as a weight loss drug.

Diabetes is a long-term condition in which blood sugar levels are too high because the body does not produce or use insulin properly. Over time, high blood sugar can cause serious health problems, including kidney and heart disease.

Mounjaro (tirzepatide) helps you control your blood sugar levels by increasing insulin production, lowering the amount of sugar your liver makes, and slowing down the rate food passes through your body. This can help you feel fuller for longer.

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist, meaning that it works on both glucose-dependent insulinotropic polypeptide (GIP) receptors and glucagon-like peptide-1 (GLP-1) receptors.

Mounjaro can be used with other diabetes medications, including metformin, sulfonylureas, and SGLT2 inhibitors. This drug has not been tested in people with pancreatitis and is not approved for use in people with type 1 diabetes.

Mounjaro uses

  • Type 2 diabetes

    So far, the Mounjaro (tirzepatide) FDA approval is for treating type 2 diabetes. According to SURPASS-2 clinical trials, it has shown to be very effective in treating type 2 diabetes, especially compared to other drugs on the market, such as semaglutide.

    The FDA does not technically approve the use of this drug for weight loss. Although Mounjaro is not approved for weight loss, it has been found to cause significant weight loss. Based on the results of the SURMOUNT-1 clinical trial, if Mounjaro were approved for weight loss, it would likely become the most effective weight loss drug available.

Anticipated Mounjaro side effects

  • The safety and tolerability profile for tirzepatide is felt to be similar to other related diabetes medicines such as semaglutide and liraglutide. Mounjaro side effects would include:

    • Nausea

    • Diarrhea

    • Constipation

    • Vomiting



    Additional study is ongoing and looking closely for other unanticipated adverse effects.  As of yet, there is no long term safety data on this drug.

    If you experience a serious allergic reaction, seek emergency medical attention immediately.

How to take Mounjaro

Mounjaro, also known as tirzepatide, is available in the following doses:  2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 ml in single-dose injection pens.  The medication is designed to be injected weekly into the skin.  After beginning at the starting dose, should additional clinical effects be needed, your doctor may recommend increasing to the next highest tirzepatide dose at 4 week intervals.

Who should not take Mounjaro

Mounjaro can’t be used by anyone pregnant, plans to become pregnant within the next 3 months, or is breastfeeding. Mounjaro (tirzepatide) also should not be used if you have ever had pancreatitis, medullary thyroid carcinoma (thyroid C cell tumors), or if there is a personal or family history of medullary thyroid cancer or something called the MEN2 (multiple endocrine neoplasias) syndrome.

It is important to note that Mounjaro has been shown to decrease the effectiveness of oral birth control.  Patients using oral hormonal contraceptives should switch to a non-oral contraceptive method before starting this medication.